Baraff L J, Bass J W, Fleisher G R, Klein J O, McCracken G H, Powell K R, Schriger D L
UCLA Emergency Medicine Center.
Ann Emerg Med. 1993 Jul;22(7):1198-210. doi: 10.1016/s0196-0644(05)80991-6.
To develop guidelines for the care of infants and children from birth to 36 months of age with fever without source.
An expert panel of senior academic faculty with expertise in pediatrics and infectious diseases or emergency medicine.
A comprehensive literature search was used to identify all publications pertinent to the management of the febrile child. When appropriate, meta-analysis was used to combine the results of multiple studies. One or more specific management strategies were proposed for each of the decision nodes in draft management algorithms. The draft algorithms, selected publications, and the meta-analyses were provided to the panel, which determined the final guidelines using the modified Delphi technique.
All toxic-appearing infants and children and all febrile infants less than 28 days of age should be hospitalized for parenteral antibiotic therapy. Febrile infants 28 to 90 days of age defined at low risk by specific clinical and laboratory criteria may be managed as outpatients if close follow-up is assured. Older children with fever less than 39.0 C without source need no laboratory tests or antibiotics. Children 3 to 36 months of age with fever of 39.0 C or more and whose WBC count is 15,000/mm3 or more should have a blood culture and be treated with antibiotics pending culture results. Urine cultures should be obtained from all boys 6 months of age or less and all girls 2 years of age or less who are treated with antibiotics.
These guidelines do not eliminate all risk or strictly confine antibiotic treatment to children likely to have occult bacteremia. Physicians may individualize therapy based on clinical circumstances or adopt a variation of these guidelines based on a different interpretation of the evidence.
制定针对出生至36个月无明确病因发热婴幼儿的护理指南。
由儿科学、传染病学或急诊医学领域的资深学术教员组成的专家小组。
通过全面的文献检索来确定所有与发热儿童管理相关的出版物。在适当情况下,采用荟萃分析来合并多项研究的结果。针对管理算法草案中的每个决策节点提出了一种或多种具体管理策略。将算法草案、选定的出版物和荟萃分析结果提供给专家小组,该小组使用改良的德尔菲技术确定最终指南。
所有出现中毒症状的婴幼儿以及所有年龄小于28天的发热婴幼儿均应住院接受肠外抗生素治疗。根据特定临床和实验室标准定义为低风险的28至90天龄发热婴幼儿,若能确保密切随访,可作为门诊患者处理。体温低于39.0℃且无明确病因的大龄儿童无需进行实验室检查或使用抗生素。3至36个月龄、体温达到或超过39.0℃且白细胞计数为15,000/mm³或更高的儿童应进行血培养,并在培养结果出来之前接受抗生素治疗。对于所有接受抗生素治疗的6个月龄及以下男童和2岁龄及以下女童,均应进行尿培养。
这些指南并不能消除所有风险,也没有将抗生素治疗严格局限于可能患有隐匿性菌血症的儿童。医生可根据临床情况进行个体化治疗,或基于对证据的不同解读采用这些指南的变体。